Monte Rosa Therapeutics Inc (GLUE) valuation · rev $123.7M
Monte Rosa Therapeutics Inc (GLUE) rev $123.7M.
| Metric | Value |
|---|---|
| Market cap | $1.56B |
| Revenue | $123.7M |
| P/S | 12.6 |
| P/B | 3.0 |
GLUE valuation FAQ
What is GLUE's market cap?
Monte Rosa Therapeutics Inc (GLUE) market cap is $1.56B on the latest cached fundamentals snapshot.
What is GLUE's latest revenue?
Latest cached Monte Rosa Therapeutics Inc (GLUE) revenue was $123.7M. Statements: https://lician.com/financials/glue
What is GLUE's price-to-sales ratio?
Monte Rosa Therapeutics Inc (GLUE) price-to-sales (P/S) is 12.6, cached market cap $1.56B divided by revenue $123.7M.
What is GLUE's price-to-book ratio?
Monte Rosa Therapeutics Inc (GLUE) price-to-book (P/B) is 3.0 on the latest cached fundamentals snapshot.
How many GLUE valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Monte Rosa Therapeutics Inc (GLUE): Market cap, Revenue, P/S, and P/B.
Where is GLUE valuation listed?
Cached valuation multiples for Monte Rosa Therapeutics Inc (GLUE) are listed at https://lician.com/valuation/glue.
Not investment advice. Cached rows, not a live tape.